Tag: SAE reporting timelines

How to Determine Medical Significance in Adverse Event Reporting

September 2, 2025

How to Determine Medical Significance in Adverse Event Reporting Evaluating Medical Significance in Adverse Event Reporting Understanding the Concept of Medical Significance In global clinical trials, not every adverse event is straightforward to classify. Some events, while not meeting classical seriousness criteria such as hospitalization or death, may still qualify as Serious Adverse Events (SAEs)…

Adverse Event Reporting and Management, AE vs SAE Differentiation

Safety Monitoring Committees for Vulnerable Populations

August 19, 2025

digi

Safety Monitoring Committees for Vulnerable Populations How to Set Up and Run Safety Monitoring Committees for Vulnerable Populations Why Specialized Safety Committees Are Critical for Pediatric and Geriatric Trials Safety Monitoring Committees—commonly called Data Safety Monitoring Boards (DSMBs) or Data Monitoring Committees (DMCs)—are not just governance niceties. In pediatric and geriatric studies, they are the…

Dosing and Safety Assessments, Pediatric and Geriatric Clinical Trials

SAE Reporting Timelines to Regulatory Authorities: A Complete Guide

July 1, 2025

digi

SAE Reporting Timelines to Regulatory Authorities: A Complete Guide Understanding SAE Reporting Timelines to Regulatory Authorities Timely reporting of Serious Adverse Events (SAEs) is a critical regulatory requirement in clinical trials. Failure to adhere to mandated timelines can result in non-compliance, delayed approvals, and even trial suspension. This guide provides a comprehensive overview of SAE…

Safety Reporting and Pharmacovigilance, Serious Adverse Event (SAE) Management

Compensation Rules for Clinical Trial Injury under CDSCO: A Detailed Guide

May 15, 2025

digi

Compensation Rules for Clinical Trial Injury under CDSCO: A Detailed Guide Understanding CDSCO’s Compensation Rules for Clinical Trial Injuries in India India’s clinical research environment has evolved with an emphasis on ethical conduct and subject safety. One significant development was the implementation of compensation rules for clinical trial-related injuries under the Central Drugs Standard Control…

CDSCO (India) Guidelines, Regulatory Guidelines